Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 3
1997 3
1998 3
1999 5
2000 6
2001 3
2002 12
2003 12
2004 13
2005 18
2006 14
2007 11
2008 23
2009 24
2010 20
2011 31
2012 34
2013 39
2014 38
2015 40
2016 46
2017 42
2018 49
2019 50
2020 65
2021 74
2022 64
2023 67
2024 68
2025 63
2026 48

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

851 results

Results by year

Filters applied: . Clear all
Page 1
Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura.
Scully M, Cataland SR, Peyvandi F, Coppo P, Knöbl P, Kremer Hovinga JA, Metjian A, de la Rubia J, Pavenski K, Callewaert F, Biswas D, De Winter H, Zeldin RK; HERCULES Investigators. Scully M, et al. Among authors: peyvandi f. N Engl J Med. 2019 Jan 24;380(4):335-346. doi: 10.1056/NEJMoa1806311. Epub 2019 Jan 9. N Engl J Med. 2019. PMID: 30625070 Free article. Clinical Trial.
von Willebrand disease.
Seidizadeh O, Eikenboom JCJ, Denis CV, Flood VH, James P, Lenting PJ, Baronciani L, O'Donnell JS, Lillicrap D, Peyvandi F. Seidizadeh O, et al. Among authors: peyvandi f. Nat Rev Dis Primers. 2024 Jul 25;10(1):51. doi: 10.1038/s41572-024-00536-8. Nat Rev Dis Primers. 2024. PMID: 39054329 Review.
ISTH guidelines for treatment of thrombotic thrombocytopenic purpura.
Zheng XL, Vesely SK, Cataland SR, Coppo P, Geldziler B, Iorio A, Matsumoto M, Mustafa RA, Pai M, Rock G, Russell L, Tarawneh R, Valdes J, Peyvandi F. Zheng XL, et al. Among authors: peyvandi f. J Thromb Haemost. 2020 Oct;18(10):2496-2502. doi: 10.1111/jth.15010. Epub 2020 Sep 11. J Thromb Haemost. 2020. PMID: 32914526 Free PMC article.
ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura.
Zheng XL, Vesely SK, Cataland SR, Coppo P, Geldziler B, Iorio A, Matsumoto M, Mustafa RA, Pai M, Rock G, Russell L, Tarawneh R, Valdes J, Peyvandi F. Zheng XL, et al. Among authors: peyvandi f. J Thromb Haemost. 2020 Oct;18(10):2486-2495. doi: 10.1111/jth.15006. Epub 2020 Sep 11. J Thromb Haemost. 2020. PMID: 32914582 Free PMC article.
Von Willebrand disease type 2N: An update.
Seidizadeh O, Peyvandi F, Mannucci PM. Seidizadeh O, et al. Among authors: peyvandi f. J Thromb Haemost. 2021 Apr;19(4):909-916. doi: 10.1111/jth.15247. Epub 2021 Mar 26. J Thromb Haemost. 2021. PMID: 33497541 Free article. Review.
Hemophilic arthropathy: Current knowledge and future perspectives.
Gualtierotti R, Solimeno LP, Peyvandi F. Gualtierotti R, et al. Among authors: peyvandi f. J Thromb Haemost. 2021 Sep;19(9):2112-2121. doi: 10.1111/jth.15444. Epub 2021 Jul 27. J Thromb Haemost. 2021. PMID: 34197690 Free PMC article. Review.
Thrombotic thrombocytopenic purpura: early diagnosis and effective treatment in 2025.
Azoulay E, Veyradier A, Cataland S, Joly BS, Knoebl P, Zafrani L, Wendon J, Fakhouri F, Lämmle B, Pavenski K, Biebuyck N, Vanhoorelbeke K, Chaturvedi S, Pishko AM, Donadello K, Scully M, Matsumoto M, Peyvandi F, Mingot-Castellano ME, Zheng XL, Mariotte E, Benhamou Y, Coppo P. Azoulay E, et al. Among authors: peyvandi f. Intensive Care Med. 2025 Jul;51(7):1225-1239. doi: 10.1007/s00134-025-07981-3. Epub 2025 Jul 3. Intensive Care Med. 2025. PMID: 40608084 Review.
Safety and efficacy of a fitusiran antithrombin-based dose regimen in people with hemophilia A or B: the ATLAS-OLE study.
Young G, Kavakli K, Klamroth R, Matsushita T, Peyvandi F, Pipe SW, Rangarajan S, Shen MC, Srivastava A, Sun J, Tran H, You CW, Zülfikar B, Menapace LA, Zhang C, Shen Y, Puurunen M, Demissie M, Kenet G. Young G, et al. Among authors: peyvandi f. Blood. 2025 Jun 19;145(25):2966-2977. doi: 10.1182/blood.2024027008. Blood. 2025. PMID: 40053895 Free PMC article. Clinical Trial.
Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A.
Malec L, Peyvandi F, Chan AKC, Königs C, Zulfikar B, Yuan H, Simpson M, Álvarez Román MT, Carcao M, Staber JM, Dunn AL, Chou SC, d'Oiron R, Albisetti M, Demissie M, Santagostino E, Yarramaneni A, Wong N, Abad-Franch L, Gunawardena S, Fijnvandraat K; XTEND-Kids Trial Group. Malec L, et al. Among authors: peyvandi f. N Engl J Med. 2024 Jul 18;391(3):235-246. doi: 10.1056/NEJMoa2312611. N Engl J Med. 2024. PMID: 39018533 Clinical Trial.
Rare bleeding disorders: Advances in management.
Casini A, Al-Samkari H, Hayward C, Peyvandi F. Casini A, et al. Among authors: peyvandi f. Haemophilia. 2024 Apr;30 Suppl 3:60-69. doi: 10.1111/hae.14986. Epub 2024 Mar 18. Haemophilia. 2024. PMID: 38494995 Dutch.
851 results